Osteosarcoma necrosis following chemotherapy: Innate biology versus treatment-specific

被引：26

作者：

Gorlick, R ^{[1
]}

Meyers, PA ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2003年 / 25卷 / 11期

关键词：

D O I：

10.1097/00043426-200311000-00003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：840 / 841

页数：2

共 5 条

[1] Neoadjuvant chemotherapy for osteosarcoma of the extremity - Intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome [J].

Bacci, G ;

Forni, C ;

Ferrari, S ;

Longhi, A ;

Bertoni, F ;

Mercuri, M ;

Donati, D ;

Capanna, R ;

Bernini, G ;

Briccoli, A ;

Setola, E ;

Versari, M .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (11) :845-853

[2] Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651 [J].

Goorin, AM ;

Schwartzentruber, DJ ;

Devidas, M ;

Gebhardt, MC ;

Ayala, AG ;

Harris, MB ;

Helman, LJ ;

Grier, HE ;

Link, MP .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1574-1580

[3] Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the memorial Sloan-Kettering (T12) protocol [J].

Meyers, PA ;

Gorlick, R ;

Heller, G ;

Casper, E ;

Lane, J ;

Huvos, AG ;

Healey, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2452-2458

[4]

ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO

[5]

2-E

← 1 →